In vitro-expanded donor alloantigen-specific CD4+CD25+ regulatory T cells promote experimental transplantation tolerance

被引:268
作者
Golshayan, Dela
Jiang, Shuiping
Tsang, Julia
Garin, Marina I.
Mottet, Christian
Lechler, Robert I.
机构
[1] Kings Coll London, Sch Med, Guys Hosp, Dept Nephrol & Transplantat, London SE1 9RT, England
[2] Kings Coll London, Sch Med, Univ London Kings Coll Hosp, Dept Nephrol & Transplantat, London SE1 9RT, England
[3] Kings Coll London, Sch Med, St Thomas Hosp, Dept Nephrol & Transplantat, London SE1 9RT, England
[4] Imperial Coll Sch Med, Hammersmith Hosp, Dept Immunol, London, England
[5] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England
关键词
D O I
10.1182/blood-2006-05-025460
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
CD4(+)CD25(+) regulatory T (Treg) cells play a critical role in the induction and maintenance of peripheral immune tolerance. In experimental transplantation models in which tolerance was induced, donor-specific Treg cells could be identified that were capable of transferring the tolerant state to naive animals. Furthermore, these cells appeared to have indirect allospecificity for donor antigens. Here we show that in vivo alloresponses can be regulated by donor alloantigen-specific Treg cells selected and expanded in vitro. Using autologous dendritic cells pulsed with an allopeptide from H2-K-b, we generated and expanded T-cell lines from purified Treg cells of CBA mice (H2(k)). Compared with fresh Treg cells, the cell lines maintained their characteristic phenotype, suppressive function, and homing capacities in vivo. When cotransferred with naive CD4(+)CD25(-) effector T cells after thymectomy and T-cell depletion in CBA mice that received CBK (H2(k)+K-b) skin grafts, the expanded Treg cells preferentially accumulated in the graft-draining lymph nodes and within the graft while preventing CBK but not third-party B10.A (H2(k)+D-d) skin graft rejection. In wild-type CBA, these donor-specific Treg cells significantly delayed CBK skin graft rejection without any other immunosuppression. Taken together, these data suggest that in vitro-generated tailored Treg cells could be considered a therapeutic tool to promote donor-specific transplant tolerance. (c) 2007 by The American Society of Hematology
引用
收藏
页码:827 / 835
页数:9
相关论文
共 73 条
  • [1] Intratracheal delivery of a single major histocompatibility complex class I peptide induced prolonged survival of fully allogeneic cardiac grafts and generated regulatory cells
    Akiyama, Y
    Shirasugi, N
    Aramaki, O
    Matsumoto, K
    Shimazu, M
    Kitajima, M
    Ikeda, Y
    Niimi, M
    [J]. HUMAN IMMUNOLOGY, 2002, 63 (10) : 888 - 892
  • [2] An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation
    Asseman, C
    Mauze, S
    Leach, MW
    Coffman, RL
    Powrie, F
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (07) : 995 - 1003
  • [3] Loss of direct and maintenance of indirect alloresponses in renal allograft recipients: Implications for the pathogenesis of chronic allograft nephropathy
    Baker, RJ
    Hernandez-Fuentes, MP
    Brookes, PA
    Chaudhry, AN
    Cook, HT
    Lechler, RI
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 167 (12) : 7199 - 7206
  • [4] Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells
    Battaglia, M
    Stabilini, A
    Roncarolo, MG
    [J]. BLOOD, 2005, 105 (12) : 4743 - 4748
  • [5] Benichou G, 1999, J IMMUNOL, V162, P352
  • [6] Cederbom L, 2000, EUR J IMMUNOL, V30, P1538, DOI 10.1002/1521-4141(200006)30:6<1538::AID-IMMU1538>3.0.CO
  • [7] 2-X
  • [8] Persistent allopeptide reactivity and epitope spreading in chronic rejection of organ allografts
    Ciubotariu, R
    Liu, ZR
    Colovai, AI
    Ho, E
    Itescu, S
    Ravalli, S
    Hardy, MA
    Cortesini, R
    Rose, EA
    Suciu-Foca, N
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (02) : 398 - 405
  • [9] THERAPY WITH MONOCLONAL-ANTIBODIES BY ELIMINATION OF T-CELL SUBSETS INVIVO
    COBBOLD, SP
    JAYASURIYA, A
    NASH, A
    PROSPERO, TD
    WALDMANN, H
    [J]. NATURE, 1984, 312 (5994) : 548 - 551
  • [10] CD4+CD25+ immunoregulatory T cells:: New therapeutics for graft-versus-host disease
    Cohen, JL
    Trenado, A
    Vasey, D
    Klatzmann, D
    Salomon, BL
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (03) : 401 - 406